Fujiwara Noriko, Ochiai Ryota, Shirai Yuki, Saito Yuko, Nagamura Fumitaka, Iwase Satoru, Kazuma Keiko
School of Health Sciences and Nursing, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
IMSUT Hospital, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.
Contemp Clin Trials Commun. 2017 Sep 28;8:156-161. doi: 10.1016/j.conctc.2017.09.009. eCollection 2017 Dec.
Clinical research coordinators play a pivotal role in phase I cancer clinical trials.
We clarified the care coordination and practice for patients provided by clinical research coordinators in phase I cancer clinical trials in Japan and elucidated clinical research coordinators' perspective on patients' expectations and understanding of these trials.
Fifteen clinical research coordinators participated in semi-structured interviews regarding clinical practices; perceptions of patients' expectations; and the challenges that occur before, during, and after phase I cancer clinical trials.
Qualitative content analysis showed that most clinical research coordinators observed that patients have high expectations from the trials. Most listened to patients to confirm patients' understanding and reflected on responses to maintain hope, but to avoid excessive expectations; clinical research coordinators considered avoiding unplanned endings; and they aimed to establish good relationships between patients, medical staff, and among the professional team.
Clinical research coordinators were insightful about the needs of patients and took a meticulous approach to the phase I cancer clinical trial process, allowing time to connect with patients and to coordinate the inter-professional research team. Additionally, education in advanced oncology care was valuable for comforting participants in cancer clinical trials.
临床研究协调员在癌症一期临床试验中发挥着关键作用。
我们阐明了日本癌症一期临床试验中临床研究协调员为患者提供的护理协调与实践,并阐明了临床研究协调员对患者对这些试验的期望和理解的看法。
15名临床研究协调员参与了关于临床实践、对患者期望的看法以及癌症一期临床试验前、中、后出现的挑战的半结构化访谈。
定性内容分析表明,大多数临床研究协调员观察到患者对试验抱有很高期望。大多数人倾听患者以确认其理解情况,并反思应对方式以维持希望,但要避免过高期望;临床研究协调员考虑避免意外结局;他们旨在在患者、医务人员以及专业团队之间建立良好关系。
临床研究协调员对患者需求有深刻见解,并对癌症一期临床试验过程采取细致入微的方法,留出时间与患者沟通并协调专业研究团队。此外,晚期肿瘤护理教育对于安慰癌症临床试验参与者很有价值。